Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Antonella Castagna, Maurizio Zazzi et al.|BMJ Open|2024Cited by 21
Five-Year Retrospective Italian Multicenter Study of Visceral Leishmaniasis TreatmentFrancesco Di Masi, Giustino Parruti, Giacinta Tordini et al.|Antimicrobial Agents and Chemotherapy|2013Cited by 20
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registryMaria Mazzitelli, Laura Comi, Maurizio Zazzi et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 7